Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G. Duffy, Tim F. Greten, Susanna V. Ulahannan et al.|Journal of Hepatology|2016Cited by 817
Molecular Pathways of Colon Inflammation Induced by Cancer ImmunotherapyAdrienne Luoma, Kai W. Wucherpfennig, Osama E. Rahma et al.|Cell|2020Cited by 478
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trialCharu Aggarwal, Nehal J. Lakhani, Amy Prawira et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 140
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Alexander Gusev, Sarah Abou Alaiwi et al.|Nature Medicine|2022Cited by 106